Caparros-Martin Jose A, Aglan Mona S, Temtamy Samia, Otaify Ghada A, Valencia Maria, Nevado Julián, Vallespin Elena, Del Pozo Angela, Prior de Castro Carmen, Calatrava-Ferreras Lucia, Gutierrez Pilar, Bueno Ana M, Sagastizabal Belen, Guillen-Navarro Encarna, Ballesta-Martinez Maria, Gonzalez Vanesa, Basaran Sarenur Y, Buyukoglan Ruksan, Sarikepe Bilge, Espinoza-Valdez Cecilia, Cammarata-Scalisi Francisco, Martinez-Glez Victor, Heath Karen E, Lapunzina Pablo, Ruiz-Perez Victor L
Instituto de Investigaciones BiomédicasConsejo Superior de Investigaciones Científicas-Universidad Autónoma de MadridMadridSpain; CIBER de enfermedades Raras (CIBERER)MadridSpain.
Human Genetics and Genome Research Division Centre of Excellence of Human Genetics National Research Centre Cairo Egypt.
Mol Genet Genomic Med. 2016 Dec 20;5(1):28-39. doi: 10.1002/mgg3.257. eCollection 2017 Jan.
Osteogenesis imperfecta (OI) is a heterogeneous bone disorder characterized by recurrent fractures. Although most cases of OI have heterozygous mutations in or and show autosomal dominant inheritance, during the last years there has been an explosion in the number of genes responsible for both recessive and dominant forms of this condition. Herein, we have analyzed a cohort of patients with OI, all offspring of unaffected parents, to determine the spectrum of variants accounting for these cases. Twenty patients had nonrelated parents and were sporadic, and 21 were born to consanguineous relationships.
Mutation analysis was performed using a next-generation sequencing gene panel, homozygosity mapping, and whole exome sequencing (WES).
Patients offspring of nonconsanguineous parents were mostly identified with or heterozygous changes, although there were also a few cases with and heterozygous mutations. Only one sporadic patient was a compound heterozygote for two recessive mutations. Patients offspring of consanguineous parents showed homozygous changes in a variety of genes including ,,,,,,, and . In addition, two patients born to consanguineous parents were found to have de novo heterozygous mutations demonstrating that causative variants in the collagen I structural genes cannot be overlooked in affected children from consanguineous couples. Further to this, WES analysis in probands lacking mutations in OI genes revealed deleterious variants in ,, and , which are associated with congenital indifference to pain (CIP) and Fanconi-Bickel syndrome (FBS).
This work provides useful information for clinical and genetic diagnosis of OI patients with no positive family history of this disease. Our data also indicate that CIP and FBS are conditions to be considered in the differential diagnosis of OI and suggest a positive role of and in bone development.
成骨不全症(OI)是一种以反复骨折为特征的异质性骨病。尽管大多数OI病例在 或 中有杂合突变,并表现为常染色体显性遗传,但在过去几年中,导致这种疾病隐性和显性形式的基因数量激增。在此,我们分析了一组OI患者,他们均为未受影响父母的后代,以确定导致这些病例的变异谱。20名患者的父母无血缘关系,为散发病例,21名患者出生于近亲关系家庭。
使用二代测序基因panel、纯合性定位和全外显子测序(WES)进行突变分析。
非近亲父母的后代患者大多被鉴定为 或 杂合变化,尽管也有少数病例为 和 杂合突变。只有一名散发病例是两个隐性突变的复合杂合子。近亲父母的后代患者在多种基因中表现出纯合变化,包括 、、、、、、、 和 。此外,发现两名近亲父母的后代患者有新发的 杂合突变,表明在近亲夫妇的患病子女中,I型胶原结构基因中的致病变异不能被忽视。除此之外,对OI基因无突变的先证者进行WES分析发现,、 和 中有有害变异,这些变异与先天性无痛觉(CIP)和范可尼-比克综合征(FBS)相关。
这项工作为无该病阳性家族史的OI患者的临床和基因诊断提供了有用信息。我们的数据还表明,CIP和FBS是OI鉴别诊断中需要考虑的情况,并提示 和 在骨骼发育中起积极作用。